Hemolysis and hyperhomocysteinemia caused by cobalamin deficiency: three case reports and review of the literature
2008

Hemolysis and Hyperhomocysteinemia from Vitamin B12 Deficiency: Three Case Reports

Sample size: 3 publication Evidence: moderate

Author Information

Author(s): Utkarsh Acharya, Gau Jen-Tzer, William Horvath, Paolo Ventura, Chung-Tsen Hsueh, Wayne Carlsen

Primary Institution: Ohio University College of Osteopathic Medicine

Hypothesis

Hemolytic anemia may be more prevalent in patients who have a coexisting MTHFR gene mutation and vitamin B12 deficiency possibly related to severely elevated homocysteine levels.

Conclusion

The hemolysis in these cases resolved completely after vitamin B12 treatment, indicating a strong link between vitamin B12 deficiency, MTHFR mutations, and elevated homocysteine levels.

Supporting Evidence

  • Patients with MTHFR mutations and vitamin B12 deficiency presented with hemolytic anemia and elevated homocysteine levels.
  • Complete resolution of hemolysis occurred after vitamin B12 treatments.
  • High homocysteine levels may contribute to hemolysis in vitamin B12 deficiency.

Takeaway

Some people can get very sick from not having enough vitamin B12, which can cause their blood cells to break down. In this study, three patients got better after getting vitamin B12 shots.

Methodology

Case report and literature review.

Limitations

Follow-up homocysteine levels were not measured in one case, and consent could not be obtained for one patient.

Participant Demographics

Three patients with varying ages and backgrounds, including two males and one female.

Digital Object Identifier (DOI)

10.1186/1756-8722-1-26

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication